claim
The development of NMDA modulators intended to replicate ketamine's antidepressant effects without its psychoactive effects has largely failed, with drugs like memantine proving ineffective and many candidates being abandoned after costly clinical trials.

Authors

Sources

Referenced by nodes (1)